Literature DB >> 2535733

Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference.

E L Delwart1, A T Panganiban.   

Abstract

Cells expressing specific proviruses are resistant to superinfection by viruses of the same subgroup. To investigate the role of the reticuloendotheliosis virus (REV) envelope glycoprotein (env-gp) in the establishment of resistance to superinfection, we constructed plasmids that express either the wild-type env-gp or an env-gp derivative that lacks part of the transmembrane (TM) protein. After transfection, transient expression of the wild-type env gene resulted in syncytium formation in a mammalian cell line permissive for virus replication, whereas synthesis of the TM-defective env-gp did not result in syncytium formation. Several stable cell lines expressing either the normal or TM-defective env-gp were isolated. Expression of the normal env-gp in the absence of expression of other viral genes induced resistance to infection by REV. Immunofluorescence analysis of cells expressing the TM-defective env derivative and an examination of the glycosylation pattern of this peptide indicated that it is not translocated to the cell surface but resides primarily in the rough endoplasmic reticulum. However, these cells were also resistant to REV infection. Thus, interaction between the env derivative and the cellular component that functions as a receptor for the virus can occur in the endoplasmic reticulum and renders the cell immune to superinfection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535733      PMCID: PMC247682     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.

Authors:  J Sodroski; W C Goh; C Rosen; K Campbell; W A Haseltine
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

Review 2.  Inhibitors of oligosaccharide processing.

Authors:  U Fuhrmann; E Bause; H Ploegh
Journal:  Biochim Biophys Acta       Date:  1985-06-24

3.  The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation.

Authors:  J L Marsh; M Erfle; E J Wykes
Journal:  Gene       Date:  1984-12       Impact factor: 3.688

4.  Relationship between the cellular resistance to Friend murine leukemia virus infection and the expression of murine leukemia virus-gp70-related glycoprotein on cell surface of BALB/c-Fv-4wr mice.

Authors:  K Kai; H Sato; T Odaka
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

5.  Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS.

Authors:  J I Mullins; C S Chen; E A Hoover
Journal:  Nature       Date:  1986 Jan 23-29       Impact factor: 49.962

6.  Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85.

Authors:  A J Dorner; J M Coffin
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

7.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.

Authors:  J D Lifson; G R Reyes; M S McGrath; B S Stein; E G Engleman
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

8.  Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli.

Authors:  K Nagai; M F Perutz; C Poyart
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.

Authors:  R A Gruters; J J Neefjes; M Tersmette; R E de Goede; A Tulp; H G Huisman; F Miedema; H L Ploegh
Journal:  Nature       Date:  1987 Nov 5-11       Impact factor: 49.962

View more
  45 in total

1.  Sequence variability of Borna disease virus: resistance to superinfection may contribute to high genome stability in persistently infected cells.

Authors:  S Formella; C Jehle; C Sauder; P Staeheli; M Schwemmle
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Interference established in mice by infection with Friend murine leukemia virus.

Authors:  T Mitchell; R Risser
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor.

Authors:  J M Heard; O Danos
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells.

Authors:  R Gautier; A Jiang; V Rousseau; R Dornburg; T Jaffredo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  P R Donahue; S L Quackenbush; M V Gallo; C M deNoronha; J Overbaugh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation.

Authors:  T A Weaver; A T Panganiban
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes.

Authors:  F L Cosset; C Legras; Y Chebloune; P Savatier; P Thoraval; J L Thomas; J Samarut; V M Nigon; G Verdier
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

Review 8.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

9.  An equine infectious anemia virus variant superinfects cells through novel receptor interactions.

Authors:  Melinda A Brindley; Baoshan Zhang; Ronald C Montelaro; Wendy Maury
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.